Healthcare ❯ Clinical Trials

Phase 2 Trials

Male Contraceptive Trials Depression Treatment Randomized Controlled Trials Drug Efficacy

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Genmab will launch a fully financed $97-per-share tender offer with closing targeted for early 2026.

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion